Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
    • Semiconductors
  • Disclosures
    • Semiconductors
    • Energy
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form
  • [Disclosure] Daeduck Electronics (353200) – Provisional Operating Results (Consolidated Financial Basis) / 2026-07-31 Disclosures
  • [Disclosure] Hyundai Motor (005380) – Investor Relations (IR) Announcement / 2026-04-07 Disclosures
  • [Disclosure] Hanwha Aerospace (012450) – Execution of Single Sales or Supply Contract / 2025-10-27 Disclosures
  • [Disclosure] Celltrion (068270) – Additional Listing (Bonus Issue) / 2025-07-22 Bio & Healthcare
  • [Disclosure] Samsung Electronics(005930) – Decision on Acquisition of Treasury Stock / 2026-03-18 Disclosures
  • [Research] SK hynix (000660 / SKHY) – Mirae Asset | Memory Pricing · Supply Deficit · Valuation Appeal / 2026-03-04 Semiconductors
  • [Disclosure] Hyundai Motor (005380) – Provisional Sales Performance / 2024-01-03 Disclosures
  • [Disclosure] Hanwha Systems (272210) – Other Management Matters (Voluntary Disclosure) / 2025-12-16 Disclosures

[Disclosure] Celltrion (068270) – Consolidated Financial Results (Provisional Earnings Release) / 2026-05-06

Posted on May 6, 2026August 6, 2026 By K-STOCK Editor

Fact Source: Financial Supervisory Service DART

💡 3-Second Summary

Celltrion reported provisional Q1 2026 consolidated revenue of KRW 1.14T and operating profit of KRW 321.87B, marking YoY increases of 36.00% and 115.41%, respectively.

📊 [Key Disclosure Details & Financial Summary]

  • Disclosure Title: Provisional Consolidated Financial Results (Fair Disclosure)
  • Reporting Period: Current Period (2026.01.01 ~ 2026.03.31) / Previous Period (2025.10.01 ~ 2025.12.31) / Same Period Last Year (2025.01.01 ~ 2025.03.31)
  • Q1 2026 Provisional Performance (Unit: KRW)
    • Revenue: KRW 1.14T (KRW 1,144,986M) — -13.92% QoQ, +36.00% YoY
    • Operating Profit: KRW 321.87B (KRW 321,870M) — -32.26% QoQ, +115.41% YoY
    • Profit Before Income Taxes: KRW 432.20B (KRW 432,199M) — -18.12% QoQ, +121.09% YoY
    • Net Profit: KRW 349.84B (KRW 349,844M) — -33.73% QoQ, +222.93% YoY
    • Net Profit Attributable to Controlling Interest: KRW 346.14B (KRW 346,143M) — -34.50% QoQ, +218.54% YoY
  • Information Provider & Date: Celltrion IR Department, May 6, 2026
  • Key Notes: Figures are provisional K-IFRS consolidated internal estimates prior to external audit review.

📝 Editor’s Comment (Key Follow-up Checkpoint)

📌 Verification of Final Audited Figures and Detailed Financial Notes

Because this filing presents unaudited provisional results based on internal settlement prior to external audit review, it is important to monitor potential variances against the final audited statements. Checking for consistency between provisional numbers and final financial statements is essential to understand the company’s precise financial position and earnings integrity. Detailed product/segment breakdowns and confirmed figures can be verified under ‘Financial Statements’ and ‘Notes to Financial Statements’ in the upcoming Q1 Quarterly Business Report or through official IR materials.

📢 Disclaimer & Source Information

Source: This content was newly generated and structured based on official data submitted to the Data Analysis, Retrieval and Transfer System (DART) of the Financial Supervisory Service.

Investment Risk Notice: This information is provided for informational and linguistic reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any specific stock. All investment decisions and financial responsibilities rest solely with the investor.

Contact: For compliance inquiries or copyright concerns, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Disclosures, Bio & Healthcare

Post navigation

Previous Post: [Disclosure] Celltrion (068270) – Decision on Retirement of Shares / 2026-05-06
Next Post: [Research] Samsung Electro-Mechanics (009150) – Mirae Asset Securities | FC-BGA CAPEX Expansion · Price Hikes · 2028F Forward Valuation / 2026-05-06

Related Posts

  • [Disclosure] ALTEOGEN (196170) – Decision on Bonus Issue / 2026-07-16 Disclosures
  • [Disclosure] Samsung Electronics (005930) – Provisional Consolidated Financial Results (Fair Disclosure) / 2026-01-29 Disclosures
  • [Disclosure] ALTEOGEN (196170) – Additional Listing (Exercise of Stock Options) / 2024-05-17 Disclosures
  • [Disclosure] Samsung Electronics (005930) – Provisional Consolidated Financial Performance (Fair Disclosure) / 2024-10-31 Semiconductors
  • [Disclosure] Celltrion (068270) – Submission of Application for Phase 3 Clinical Trial Plan for CT-P44 (Darzalex Biosimilar) in Europe (Part 1) / 2024-11-28 Disclosures
  • [Disclosure] Hanwha Ocean (042660) – Resolution on Board Meeting for General Meeting of Shareholders / 2025-02-18 Disclosures
  • [Research] SK hynix (000660 / SKHY) – Shinhan Securities | High-Value Product Leadership · 2Q Price Rebound · Target Price Raised / 2025-04-03 RESEARCH
  • [Disclosure] Samsung Electronics (005930) – Exercise and Non-Exercise of Voting Rights by Trustee / 2024-03-22 Semiconductors
  • [Disclosure] Hanmi Semiconductor (042700) – Investor Relations (IR) Presentation / 2025-09-01 Semiconductors
  • [Disclosure] Hana Micron (067310) – Suspension of Share Trading (Split) / 2025-01-17 Semiconductors
  • [Research] SK hynix (000660 / SKHY) – Kiwoom Securities | 12-High Ramp-up · Commodity Recovery · Short-Term Buy Opportunity / 2025-04-08 RESEARCH
  • [Disclosure] PSK Holdings (031980) Disposes of KRW 15.6B Treasury Shares via Block Deal to Fund Pangyo R&D Campus Semiconductors
  • [Research] SK hynix (000660 / SKHY) – Eugene Investment & Securities | HBM Supply Dominance · Earnings Revision · Valuation Re-rating / 2024-02-26 RESEARCH
  • About Us | K-Stock Briefing About Us

Copyright © 2026 K-Stock Briefing.

Powered by PressBook News Dark theme